Transcatheter leadless pacemakers have benefits in congenital heart disease because they eliminate the risks of lead malfunction, venous occlusions, and pocket complications. This newest pacemaker's utility in this population has been limited by the large sheath and delivery system, need for atrioventricular synchronous pacing, lack of explantation options, and possible lack of adequate access to the subpulmonary ventricle. With careful planning, leadless pacing can be successfully performed in these patients. Consideration of nonfemoral access, alternative implant sites to avoid myocardial scar or prosthetic material, anticoagulation for patients with persistent intracardiac shunts or systemic ventricular implantation, and operator experience are critical.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.ccep.2023.06.002 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Assessment of adverse events stratified by timing of leadless pacemaker implantation with cardiac implantable electronic devices extraction due to infection: A systematic review and meta-analysis.
J Arrhythm
February 2025
Department of Cardiology Nagoya University Graduate School of Medicine Nagoya Japan.
Background: Removal of cardiac implantable electronic devices (CIEDs) is strongly recommended for CIED-related infections, and leadless pacemakers (LPs) are increasingly used for reimplantation. However, the optimal timing and safety of LP implantation after CIED removal for infection remains unclear.This systematic review and meta-analysis aimed to assess complication rates (all-cause mortality and reinfection) when LP implantation was performed simultaneously with or after CIED removal.
View Article and Find Full Text PDFRetrieval of a dislodged leadless pacemaker: An example of the double-snare technique.
J Arrhythm
February 2025
Department of Cardiology, Pulmonology, Hypertension & Nephrology Ehime University Graduate School of Medicine Toon Japan.
A video demonstration presents the retrieval of a dislodged leadless pacemaker using the double-snare technique. Sharing troubleshooting strategies in such cases is clinically important for managing rare pacemaker complications.
View Article and Find Full Text PDFPacemaker-Induced Superior Vena Cava Syndrome.
Cureus
December 2024
Interventional Radiology, St Mary's Hospital, Waterbury, USA.
Superior vena cava (SVC) syndrome is a result of impaired blood flow from the SVC to the right atrium, leading to venous congestion in the head and neck. It can be caused by clotting disorders or compressive tumors of the head and neck but has become more prevalent in the setting of implantable devices such as pacemakers. As such, managing these patients can present challenges for physicians who have to account for SVC syndrome as well as their underlying condition requiring an implantable cardiac device.
View Article and Find Full Text PDFComparative safety of transvenous and leadless pacemakers in patients with cardiovascular diseases: A meta-analysis study.
Heliyon
January 2025
Faculty of Medicine and Medical Sciences, University of Balamand, Kalhat, Lebanon.
Background: Transvenous pacemakers (TVP) and leadless pacemakers (LP) are two reliable permanent modalities for the treatment of heart rhythm disorders. Several observational studies explored the safety and efficacy of the two devices. The aim of this meta-analysis study is to present a comparative analysis of the safety of leadless versus transvenous pacemakers.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!